Yahoo
Tokyo - Delayed Quote JPY

Eiken Chemical Co., Ltd. (4549.T)

2,307.00 +6.00 (+0.26%)
At close: October 30 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 4549.T
  • Previous Close 2,301.00
  • Open 2,297.00
  • Bid --
  • Ask 2,276.00 x --
  • Day's Range 2,258.00 - 2,334.00
  • 52 Week Range 2,021.00 - 3,500.00
  • Volume 94,100
  • Avg. Volume 175,910
  • Market Cap (intraday) 76.052B
  • Beta (5Y Monthly) 0.32
  • PE Ratio (TTM) 41.26
  • EPS (TTM) 55.91
  • Earnings Date (est.) --
  • Forward Dividend & Yield 58.00 (2.51%)
  • Ex-Dividend Date Mar 30, 2027
  • 1y Target Est --

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests reagents to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers molecular test (LAMP) using nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.

www.eiken.co.jp

696

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4549.T
2.03%
Nikkei 225 (^N225)
25.73%

1-Year Return

4549.T
0.34%
Nikkei 225 (^N225)
23.31%

3-Year Return

4549.T
71.07%
Nikkei 225 (^N225)
106.18%

5-Year Return

4549.T
38.30%
Nikkei 225 (^N225)
119.05%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 10.73B
Earnings 445M
Profit Margin 4.15%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
2B
4B
6B
8B
10B
0.0%
5.0%
10.0%
15.0%
20.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.33%

  • Return on Assets (ttm)

    2.73%

  • Return on Equity (ttm)

    4.21%

  • Revenue (ttm)

    42.86B

  • Net Income Avi to Common (ttm)

    1.85B

  • Diluted EPS (ttm)

    55.91

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.64B

  • Total Debt/Equity (mrq)

    13.11%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: